Eagle Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-257,156
Closed -$56.3M 563
2023
Q1
$56.3M Buy
257,156
+265
+0.1% +$57.5K 0.33% 109
2022
Q4
$53.7M Sell
256,891
-128
-0% -$28.1K 0.33% 112
2022
Q3
$56.1M Buy
257,019
+1,590
+0.6% +$362K 0.37% 98
2022
Q2
$53.5M Sell
255,429
-211,931
-45% -$45.1M 0.34% 109
2022
Q1
$113M Buy
467,360
+141,061
+43% +$34.1M 0.58% 57
2021
Q4
$85.5M Buy
326,299
+1,982
+0.6% +$514K 0.37% 100
2021
Q3
$85.5M Sell
324,317
-86,005
-21% -$23.5M 0.39% 101
2021
Q2
$101M Sell
410,322
-183
-0% -$38.5K 0.43% 84
2021
Q1
$79.8M Buy
410,505
+22,358
+6% +$4.48M 0.35% 106
2020
Q4
$82.5M Sell
388,147
-31,378
-7% -$6.26M 0.47% 66
2020
Q3
$72.4M Buy
419,525
+7,586
+2% +$1.4M 0.37% 108
2020
Q2
$77.6M Buy
+411,939
New +$67.4M 0.44% 89
2014
Q2
Sell
-118,427
Closed -$5.29M 663
2014
Q1
$5.29M Buy
118,427
+28,237
+31% +$1.27M 0.03% 467
2013
Q4
$4.25M Buy
90,190
+39,775
+79% +$2.01M 0.02% 460
2013
Q3
$2.66M Sell
50,415
-2,680
-5% -$130K 0.01% 600
2013
Q2
$2.4M Buy
+53,095
New +$2.52M 0.02% 582

Other funds holding RMD

Eagle Asset Management's RMD Position: Q2 2023 in Review

Eagle Asset Management sold out of ResMed (RMD) in Q2 2023, closing a stake of 257,156 shares — an estimated $56.3M sold.

Eagle Asset Management first reported a position in RMD in Q2 2013 and held it in 16 quarters. The position peaked at $113M in Q1 2022. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

  • Eagle Asset Management reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
  • Eagle Asset Management sold 257,156 ResMed shares in Q2 2023, an estimated $56.3M.
  • Eagle Asset Management first reported a position in ResMed in Q2 2013 and held it in 16 quarters.
  • Eagle Asset Management's ResMed position peaked at $113M in Q1 2022.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Eagle Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.